IMF Videos Search Content For Care Partner (21) Patient (21) Series - Any - About the IMF (2) ASCO/EHA (163) ASH (229) Ask Dr. Durie (275) Black Swan Research Initiative (7) Community Workshops (33) Emerging Therapies (20) Facebook Live (21) Health Equity (16) IMF History (4) IMWG (13) Inspirational (16) Living Well with Myeloma (34) Myeloma in a Minute (18) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (27) Q&A (19) Recent News and Developments (4) Treatments (4) Trending Searches in Myeloma (1) Topics Frontline Therapy (4) Lab & Imaging Tests (6) Lifestyle (1) Myeloma 101 (2) Public Policy & Advocacy (1) Relapse/Refractory Myeloma (3) Symptom Management (9) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (8) High-Risk Myeloma (7) High-risk Smoldering Myeloma (6) Late Relapse (4–6 Lines of Therapy) (8) MGUS (6) Newly Diagnosed (Pre-Treatment or First Treatment) (12) Smoldering Myeloma (10) Types of Therapy Immunomodulatory drugs (IMiDs) (1) Proteasome inhibitors (1) Stem cell transplant (1) Steroids (1) Supportive Care (11) Year Published 2024 (16) 2023 (29) 2022 (27) 2021 (29) 2020 (37) 2019 (30) 2018 (27) 2017 (21) 2016 (25) 2015 (34) Trusted Voices Dr. Brian GM Durie (225) Sort Newest firstOldest firstA -> ZZ -> ARelevance Can stored and harvested stem cells be used after CAR T-cell therapy? July 7, 2024 Ask Dr. Durie Does being overweight increase the risk of developing multiple myeloma? July 6, 2024 Ask Dr. Durie How frequently should TECVAYLI (teclistamab) be given to myeloma patients? July 5, 2024 Ask Dr. Durie Are four-drug combinations recommended for older transplant ineligible myeloma patients? June 25, 2024 Ask Dr. Durie What does the FDA approval of MRD testing for myeloma mean for patients and drug development? June 20, 2024 Ask Dr. Durie What is the role of ASCT in the frontline setting for African-American patients? May 9, 2024 Ask Dr. Durie Do patients with MGUS always need to undergo a bone marrow test? April 25, 2024 Ask Dr. Durie What should be done if a patient relapses while in a clinical trial? April 19, 2024 Ask Dr. Durie What are CRAB and pre-CRAB criteria in myeloma diagnosis, and how do they affect treatment decision-making? April 16, 2024 Ask Dr. Durie How valuable is minimal residual disease testing for myeloma patients? April 11, 2024 Ask Dr. Durie What concerns about the early use of CAR-T therapy were addressed in the ODAC hearing? April 4, 2024 Ask Dr. Durie What are considerations for myeloma patients regarding immune therapy targets, side effects, and monitoring? March 21, 2024 Ask Dr. Durie Load More
